Letter

2008-09-01

Additional Metadata
Keywords	antineoplastic agent, area under the curve, body surface, carboplatin, chromium 51, clinical practice, creatinine, creatinine clearance, disease severity, dose response, drug blood level, drug clearance, drug formulation, edetic acid, gynecologic cancer, human, kidney function, letter, practice guideline, priority journal, prospective study, unspecified side effect
Persistent URL	doi.org/10.1111/j.1525-1438.2007.01119.x, hdl.handle.net/1765/14851
Journal	International Journal of Gynecological Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Jong, F.A, Verweij, J, & Sparreboom, A. (2008). Letter. International Journal of Gynecological Cancer, 18(5). doi:10.1111/j.1525-1438.2007.01119.x

Publication